Evaluation and Management of Virologic Failure
10 questions
Questions in Topic
- 1. Indications for Resistance Testing
- 2. Impact of M184V Mutation on NRTIs
- 3. Impact of M184V on INSTI-Based Regimens
- 4. Thymidine Analog Mutations (TAMs)
- 5. K103N Mutation
- 6. Virologic Failure while Taking Rilpivirine
- 7. Doravirine Resistance
- 8. Darunavir Dosing with Prior Use of Protease Inhibitor
- 9. Raltegravir Resistance
- 10. Maraviroc Resistance
Learning Objectives
- Describe the management of intermittent and persistently detectable HIV RNA levels in persons receiving antiretroviral therapy
- Discuss the indications for and types of resistance testing for patients with virologic failure
- Utilize an HIV resistance database tool to assist in the optimal selection of regimens in persons with HIV drug resistance
- Summarize concepts of resistance with different antiretroviral drug classes
- Explain key considerations when selecting a salvage antiretroviral regimen in persons with virologic failure
Authors
Reviewers
3rd Edition
This is a substantial revision of the original Question Bank Topic. The previous edition was titled Evaluation and Management of Virologic Failure 2nd Edition Question Bank and was available until August 31st, 2023.
CNE/CME
Continuing Education
This lesson qualifies for:
View CE Notices
- 1.0 CME AMA PRA Category 1 Credit™, or
- 1.0 CNE contact hour and 1.0 CE contact hour (qualifies for pharmacology CE for advanced practice nurses)
CNE and CME Origination: June 1st, 2017
CNE and CME Review: September 1st, 2023
CNE and CME Expiration: August 31st, 2026 (3rd Edition)
View CE Notices
Steps to acquire a Certificate for this Lesson:
1
Answer Questions
Answer the board-review style questions
2
Answer Correctly
Score 80% on questions
3
Give Feedback
Complete survey
4
Print Certificate
Document work Explore this topic in detail in the Evaluation and Management of Virologic Failure Quick Reference,
or earn more CE for it in the Evaluation and Management of Virologic Failure Self-Study
or earn more CE for it in the Evaluation and Management of Virologic Failure Self-Study